Amy R. Peck

Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment

Kanstantsin V. Katlinski, Jun Gui, Yuliya V. Katlinskaya et al. · Cancer Cell · 2017 · 249 citations

Medicine, Cancer Biology, Immunology +14

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

Xuanmao Jiao, Marco A. Velasco‐Velázquez, Min Wang et al. · Cancer Research · 2018 · 126 citations · Full text

Medicine, Cancer Biology, Oncology +17

Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells

Victoria Gennaro, Timothy J. Stanek, Amy R. Peck et al. · Proceedings of the National Academy of Sciences · 2018 · 125 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure

Amy R. Peck, Agnieszka K. Witkiewicz, Chengbao Liu et al. · Journal of Clinical Oncology · 2011 · 104 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

Amy R. Peck, Agnieszka K. Witkiewicz, Chengbao Liu et al. · Breast Cancer Research · 2012 · 75 citations · Full text

Medicine, Molecular Biology, Oncology +13